ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts Of Five Contract Recompetitions

October 14, 1983

MAP Says It Will Continue Operating With Private Funds

April 18, 1986

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979

Foundation offers funds for mesothelioma research.

July 9, 2004

New Report On Survival Data Available From NCI

July 25, 1975

IOM Appoints 17 To National Cancer Policy Board

February 7, 1997